SCHEMBL8260342

SCHEMBL8260342

CC(C)c1cnc(NC(=O)[C@H](C)NC(=O)[C@@H](O)C(C)C)s1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 7/20 0.65
CCNE1 P24864 6/20 0.65
CDK5 Q00535 6/20 0.65
PSEN1 P49768 10/20 0.55
PSEN2 P49810 10/20 0.55
APH1B Q8WW43 10/20 0.55
NCSTN Q92542 10/20 0.55
APH1A Q96BI3 10/20 0.55
PSENEN Q9NZ42 10/20 0.55
CCNT1 O60563 1/20 0.48
ALDH1A1 P00352 1/20 0.48
CDK1 P06493 1/20 0.48
CDK4 P11802 1/20 0.48
CCNB1 P14635 1/20 0.48
CCNA2 P20248 1/20 0.48
CCND1 P24385 1/20 0.48
CDK7 P50613 1/20 0.48
CDK9 P50750 1/20 0.48
CCNH P51946 1/20 0.48
MNAT1 P51948 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5875523 1.00 CDK2 (0.65) CDK2CCNE1CDK5PSEN1PSEN2
SCHEMBL5875507 0.87 PSEN1 (0.71) CDK2CCNE1CDK5PSEN1PSEN2
SCHEMBL8257260 0.87 PSEN1 (0.71) CDK2CCNE1CDK5PSEN1PSEN2
SCHEMBL8258681 0.87 CDK2 (0.55) CDK2CCNE1CDK5PSEN1PSEN2
SCHEMBL5875482 0.87 CDK2 (0.55) CDK2CCNE1CDK5PSEN1PSEN2
SCHEMBL5875658 0.85 PSEN1 (0.65) CDK2CCNE1CDK5PSEN1PSEN2
SCHEMBL8258601 0.85 PSEN1 (0.65) CDK2CCNE1CDK5PSEN1PSEN2
SCHEMBL5836593 0.85 CDK2 (0.70) CDK2CCNE1CDK5PSEN1PSEN2
SCHEMBL27569831 0.85 CDK2 (0.70) CDK2CCNE1CDK5PSEN1PSEN2
SCHEMBL8258691 0.83 PSEN1 (0.80) CDK2CCNE1CDK5PSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040152747-A1 Thiazole compounds for treatment of neurodegenerative disorders PFIZER INC 2004-08-05 US disclosed
US-20040152747-A1 Thiazole compounds for treatment of neurodegenerative disorders PFIZER INC 2004-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040152747-A1 Thiazole compounds for treatment of neurodegenerative disorders APP, PARK7, IAPP CDK2 1792/4885CCNE1 1853/4885CDK5 506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.